Showing 1 - 10 of 3,626
Background Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the negotiated price for new patented drugs in Germany. European reference prices (ERPs) are one criterion. The ERP is based on the ex-factory prices...
Persistent link: https://www.econbiz.de/10015358230
The co-existence of external referencing pricing (ERP) and reimbursement policy is common in many countries. Thus, this research examines whether or not the imposition of ERP is socially desirable in the presence of reimbursement policy. For direct sales channel, we find that the home social...
Persistent link: https://www.econbiz.de/10014369574
To meet the requirements of global competition, the European Union (EU) places particular emphasis on the development of knowledge‑intensive, innovative industries. The pharmaceutical industry, as a high‑tech manufacturing subsection, has a long tradition in Europe. However, the distribution...
Persistent link: https://www.econbiz.de/10012665037
Persistent link: https://www.econbiz.de/10012221319
Persistent link: https://www.econbiz.de/10012221376
Persistent link: https://www.econbiz.de/10011448268
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects …
Persistent link: https://www.econbiz.de/10009240823
I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by investigating whether there were larger declines in the age-standardized mortality rate of cancer sites (breast, lung, colon, etc.) that were subject to more pharmaceutical...
Persistent link: https://www.econbiz.de/10011885726
Drug overdose deaths, primarily due to opioid addiction, have devastated communities in almost every area of the U.S. The economic impacts of the crisis include additional healthcare resources, unemployment, lost productivity, criminal justice costs, and other indirect impacts that have not yet...
Persistent link: https://www.econbiz.de/10012237489
The aim of this paper is to discuss the common features and specificity of Corporate Social Responsibility (CSR) practices of innovative transnational corporations (TNCs) acting in the pharmaceutical industry. The innovativeness of pharmaceutical firms is understood here as their ability to make...
Persistent link: https://www.econbiz.de/10011960021